Additionally, KRAS‐UP signalling was most prominently upregulated in KC2, followed by KC3, suggesting that KC2 tumours might be highly sensitive to G12Ci, whereas KC1 tumours may exhibit resistance. Here, UPP1 is linked to neoplasm.